Immunoablative high-dose cyclophosphamide without stem cell rescue in paraneoplastic pemphigus: Report of a case and review of this new therapy for severe autoimmune disease
- 1 May 1999
- journal article
- case report
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 40 (5) , 750-754
- https://doi.org/10.1016/s0190-9622(99)70157-x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice.Journal of Clinical Investigation, 1998
- Course of Crohn's disease after allogeneic marrow transplantationGastroenterology, 1998
- Long‐term outcome of autoimmune disease following allogeneic bone marrow transplantationArthritis & Rheumatism, 1998
- HAEMOPOIETIC STEM CELL TRANSPLANTATION FOR AUTOIMMUNE DISEASESBritish Journal of Haematology, 1997
- cDNA Cloning of the 210-kDa Paraneoplastic Pemphigus Antigen Reveals that Envoplakin Is a Component of the Antigen ComplexJournal of Investigative Dermatology, 1997
- Increased expression of Fas antigen on bone marrow CD34+ cells of patients with aplastic anaemiaBritish Journal of Haematology, 1995
- Beneficial Effects of Bone Marrow Transplantation on the Serological Manifestations and Kidney Pathology of Experimental Systemic Lupus ErythematosusCellular Immunology, 1995
- Chronic-relapsing experimental autoimmune encephalomyelitis (CR-EAE): treatment and induction of tolerance, with high dose cyclophosphamide followed by syngeneic bone marrow transplantationJournal of Neuroimmunology, 1992
- Paraneoplastic PemphigusNew England Journal of Medicine, 1990
- 4-Hydroperoxycyclophosphamide inhibits proliferation by human granulocytemacrophage colony-forming cells (GM-CFC) but spares more primitive progenitor cellsLeukemia Research, 1985